The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data

Background: In heart failure (HF), obesity, defined as body mass index (BMI) ⩾30 kg m −2 , is paradoxically associated with higher survival rates compared with normal-weight patients (the ‘obesity paradox’). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fract...

Full description

Saved in:
Bibliographic Details
Published inInternational Journal of Obesity Vol. 38; no. 8; pp. 1110 - 1114
Main Authors Padwal, R, McAlister, F A, McMurray, J J V, Cowie, M R, Rich, M, Pocock, S, Swedberg, K, Maggioni, A, Gamble, G, Ariti, C, Earle, N, Whalley, G, Poppe, K K, Doughty, R N, Bayes-Genis, A
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.08.2014
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: In heart failure (HF), obesity, defined as body mass index (BMI) ⩾30 kg m −2 , is paradoxically associated with higher survival rates compared with normal-weight patients (the ‘obesity paradox’). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fraction (HF-REF) versus preserved ejection fraction (HF-PEF)). Patients and Methods: A sub-analysis of the MAGGIC meta-analysis of patient-level data from 14 HF studies was performed. Subjects were divided into five BMI groups: <22.5, 22.5–24.9 (referent), 25–29.9, 30–34.9 and ⩾35 kg m −2 . Cox proportional hazards models adjusted for age, sex, aetiology (ischaemic or non-ischaemic), hypertension, diabetes and baseline blood pressure, stratified by study, were used to examine the independent association between BMI and 3-year total mortality. Analyses were conducted for the overall group and within HF-REF and HF-PEF groups. Results: BMI data were available for 23 967 subjects (mean age, 66.8 years; 32% women; 46% NYHA Class II; 50% Class III) and 5609 (23%) died by 3 years. Obese patients were younger, more likely to receive cardiovascular (CV) drug treatment, and had higher comorbidity burdens. Compared with BMI levels between 22.5 and 24.9 kg m −2 , the adjusted relative hazards for 3-year mortality in subjects with HF-REF were: hazard ratios (HR)=1.31 (95% confidence interval=1.15–1.50) for BMI <22.5, 0.85 (0.76–0.96) for BMI 25.0–29.9, 0.64 (0.55–0.74) for BMI 30.0–34.9 and 0.95 (0.78–1.15) for BMI ⩾35. Corresponding adjusted HRs for those with HF-PEF were: 1.12 (95% confidence interval=0.80–1.57) for BMI <22.5, 0.74 (0.56–0.97) for BMI 25.0–29.9, 0.64 (0.46–0.88) for BMI 30.0–34.9 and 0.71 (0.49–1.05) for BMI ⩾35. Conclusions: In patients with chronic HF, the obesity paradox was present in both those with reduced and preserved ventricular systolic function. Mortality in both HF subtypes was U-shaped, with a nadir at 30.0–34.9 kg m −2 .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
content type line 23
ISSN:0307-0565
1476-5497
1476-5497
DOI:10.1038/ijo.2013.203